Dr Gonzalo Tapia Rico

Medical Oncologist
Become a Patient

Dr Gonzalo Tapia Rico is committed to achieving the best possible outcome for his patients. He prides himself in building strong, lasting relationships with his patients and supporting them every step of the way.


Dr Gonzalo Tapia Rico is an experienced medical oncologist at Icon Cancer Centre Adelaide and Icon Cancer Centre Windsor Gardens. He undertook his medical training at the Complutense University of Madrid and completed medical oncology training at one of Spain’s most prestigious hospitals, Gregorio Marañón Hospital. In 2013 he received his PhD degree for research exploring alternative classifications of molecular subtypes in breast cancer.

Dr Tapia Rico subsequently worked as a medical oncologist in the United Kingdom at the Royal Infirmary and Western General Hospitals in Edinburgh and Addenbrooke’s Hospital in Cambridge. He moved to Australia in 2016. As medical oncology clinical research fellow at both The Queen Elizabeth Hospital and Royal Adelaide Hospital, he gained extensive knowledge and experience in all aspects of cancer clinical trials with the overarching desire to make meaningful improvements to patients’ outcomes.

Dr Tapia Rico maintains a strong interest in education, clinical trials and research in both his private practice and roles as Clinical Senior Lecturer at the University of Adelaide and Clinical Director of Education at Icon Cancer Centre Adelaide. He has published numerous peer-reviewed articles in leading publications such as Cancer Treatment Reviews and Critical Reviews in Oncology/Hematology. Dr Tapia Rico is a fellow of the Royal Australasian College of Physicians (FRACP) and a member of several leading Australian and international cancer research groups.

His clinical experience covers a broad range of solid tumour malignancies with special clinical interest in immunotherapy, clinical trials, melanoma, gastrointestinal, lung, thyroid and breast cancers. Dr Tapia Rico can converse in Spanish and looks forward to working with patients in their language.

Affiliations & Memberships

  • Australasian Gastro-Intestinal Trials Group (AGITG)
  • European Society of Medical Oncology (ESMO)
  • Spanish Group of Breast Cancer Research (GEICAM)
  • Royal Australasian College of Physicians (RACP)
  • Spanish Society of Medical Oncology (SEOM)

Special Interests

Dr Gonzalo Tapia Rico accepts referrals for all cancer types, with a special clinical interest in:
  • Breast cancer
  • Clinical research
  • Gastrointestinal cancer
  • Lung cancer
  • Melanoma

Icon Locations

Adelaide (Kurralta Park) View centre
Adelaide (Windsor Gardens) View centre


  • Immunotherapy in older patients with advanced melanoma: a review of current evidence. T. Foo, G. Tapia Rico & R. Roberts-Thomson. Drugs & Aging, 2020; 37, 411-423.

  • The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence. G. Tapia Rico, M.M Chan & K.F Loo. Cancer Treat Rev, 2020 Jun; 86:102011.

  • The “pet effect” in cancer patients: risks and benefits of human-pet interaction. M.M. Chan & G Tapia Rico. Critical Reviews in Oncology/Haematology, 2019; 143, 56-61.

  • Atezolizumab for the treatment of colorectal cancer: the latest evidence and clinical potential. G. Tapia-Rico & T.J. Price. Expert Opin Biol Ther, 2018 Apr; 18(4):449-457.

  • Prevention and management of carcinoid crises in patients with high-risk neuroendocrine tumours undergoing peptide receptor radionuclide therapy (PRRT): Literature review and case series from two Australian tertiary medical institutions. G. Tapia Rico, M.Li, N. Pavlakis, C. Cehic & T.J. Price. Cancer Treat Rev. 2018 May;66:1-6.